Zymeworks Inc (ZYME)
NASDAQ:ZYME
Want to see ZYME full AI Analyst Report?
Total Valuation
Zymeworks has a market cap or net worth of $1.76B. The enterprise value is -$225.48B.
Market Cap$1.76B
Enterprise Value-$225.48B
Share Statistics
Zymeworks has 73,023,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding73,023,060
Owned by Insiders32.73%
Owned by Institutions3.54%
Financial Efficiency
Zymeworks’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -30.08%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-30.08%
Return on Capital Employed (ROCE)-0.30
Revenue Per Employee354.40K
Profits Per Employee-271.34K
Employee Count299
Asset Turnover0.31
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zymeworks is ―. Zymeworks’s PEG ratio is 0.73.
PE Ratio―
PS Ratio18.72
PB Ratio7.39
Price to Fair Value7.39
Price to FCF-57.45
Price to Operating Cash Flow-0.04
PEG Ratio0.73
Income Statement
In the last 12 months, Zymeworks had revenue of 105.97M and earned -81.13M in profits. Earnings per share was -1.08.
Revenue105.97M
Gross Profit105.97M
Operating Income-92.53M
Pretax Income-79.75M
Net Income-81.13M
EBITDA-81.42M
Earnings Per Share (EPS)-1.08
Cash Flow
In the last 12 months, operating cash flow was -45.75B and capital expenditures -2.08M, giving a free cash flow of -45.75B billion.
Operating Cash Flow-45.75B
Free Cash Flow-45.75B
Free Cash Flow per Share-626.50
Dividends & Yields
Zymeworks pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.98
52-Week Price Change98.75%
50-Day Moving Average24.39
200-Day Moving Average20.31
Relative Strength Index (RSI)64.89
Average Volume (3m)641.83K
Important Dates
Zymeworks upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Zymeworks as a current ratio of 5.52, with Debt / Equity ratio of 10.42%
Current Ratio5.52
Quick Ratio5.52
Debt to Market Cap<0.01
Net Debt to EBITDA0.28
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Zymeworks has paid 1.38M in taxes.
Income Tax1.38M
Effective Tax Rate-0.02
Enterprise Valuation
Zymeworks EV to EBITDA ratio is -24.08, with an EV/FCF ratio of -56.79.
EV to Sales18.50
EV to EBITDA-24.08
EV to Free Cash Flow-56.79
EV to Operating Cash Flow-59.41
Balance Sheet
Zymeworks has $364.73B in cash and marketable securities with $17.04B in debt, giving a net cash position of $347.69B billion.
Cash & Marketable Securities$364.73B
Total Debt$17.04B
Net Cash$347.69B
Net Cash Per Share$4.76K
Tangible Book Value Per Share-$173.85
Margins
Gross margin is 94.42%, with operating margin of -87.33%, and net profit margin of -76.56%.
Gross Margin94.42%
Operating Margin-87.33%
Pretax Margin-75.26%
Net Profit Margin-76.56%
EBITDA Margin-76.84%
EBIT Margin-87.33%
Analyst Forecast
The average price target for Zymeworks is $39.89, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$39.89
Price Target Upside43.49% Upside
Analyst ConsensusStrong Buy
Analyst Count11
Revenue Growth Forecast-12.98%
EPS Growth Forecast8.99%